Mott David M
SEC-identified person · CIK 1219871 Identifier-verified
Public-company roles (from insider filings)
| Company | Capacity as filed | Filings |
|---|---|---|
| Novavax INC nvax | Director | filed 2020–2026 |
| Ardelyx, INC. ARDX | Director | filed 2014–2026 |
| Mersana Therapeutics, Inc. [MRSN] | Director | filed 2017–2026 |
| Adaptimmune Therapeutics PLC ADAP] | Director | filed 2016–2024 |
| Epizyme, Inc. EPZM | Director | filed 2013–2022 |
| Imara Inc. IMRA | Director | filed 2020–2022 |
| Casper Sleep Inc. CSPR | Officer | filed 2020–2020 |
| Black Diamond Therapeutics, Inc. BDTX | Officer | filed 2020–2020 |
| Regulus Therapeutics Inc. RGLS | Officer | filed 2017–2019 |
| Sprout Social, Inc. SPT | Officer | filed 2019–2019 |
| Galera Therapeutics, Inc. GRTX | Officer | filed 2019–2019 |
| Oyster Point Pharma, Inc. OYST | Officer | filed 2019–2019 |
| Cloudflare, Inc. NET | Officer | filed 2019–2019 |
| Mirum Pharmaceuticals, Inc. MIRM | Officer | filed 2019–2019 |
| Genocea Biosciences, INC. GNCA | Officer | filed 2018–2019 |
| Nightstar Therapeutics plc NITE | Director | filed 2019–2019 |
| Trevi Therapeutics, Inc. TRVI | Officer | filed 2019–2019 |
| Aveo Pharmaceuticals, INC. AVEO | Officer | filed 2016–2019 |
| Tesaro, Inc. TSRO | Director | filed 2012–2019 |
| Ra Pharmaceuticals, Inc. RARX | Officer | filed 2016–2018 |
| Tempest Therapeutics, Inc. TPST | Officer | filed 2018–2018 |
| Phasebio Pharmaceuticals Inc PHAS | Officer | filed 2018–2018 |
| Tapimmune INC. TPIV.OB | Officer | filed 2018–2018 |
| Elastic N.V. ESTC | Officer | filed 2018–2018 |
| Mulesoft, INC MULE | Officer | filed 2017–2018 |
| Surface Oncology, Inc. SURF | Officer | filed 2018–2018 |
| Tracon Pharmaceuticals, Inc. TCON | Officer | filed 2015–2018 |
| Oncothyreon Inc. ONTY | Officer | filed 2017–2018 |
| Oruka Therapeutics, Inc. ORKA | Officer | filed 2015–2018 |
| Appian Corp APPN | Officer | filed 2017–2018 |
| Synlogic, INC. SYBX | Officer | filed 2015–2018 |
| Strongbridge Biopharma plc SBBP | Officer | filed 2018–2018 |
| X4 Pharmaceuticals, Inc XFOR | Officer | filed 2017–2017 |
| Care.com Inc CRCM | Officer | filed 2014–2017 |
| Rhythm Pharmaceuticals, INC. SRYTM | Officer | filed 2017–2017 |
| Achaogen, Inc. AKAO | Officer | filed 2016–2016 |
| Roka Bioscience, Inc. ROKA | Officer | filed 2014–2016 |
| Interleukin Genetics INC ILIU | Officer | filed 2013–2016 |
| Cerecor Inc. CERC | Officer | filed 2015–2015 |
| Champions Sports INC csbr | Officer | filed 2015–2015 |
| BOX INC BOX | Officer | filed 2015–2015 |
| Cvent INC CVT | Officer | filed 2013–2014 |
| Dermira, Inc. DERM | Officer | filed 2014–2014 |
| Loxo Oncology, Inc. LOXO | Officer | filed 2014–2014 |
| Aerohive Networks, INC HIVE | Officer | filed 2014–2014 |
| Glycomimetics INC GLYC | Officer | filed 2014–2014 |
| Omthera Pharmaceuticals, Inc. OMTH | Director | filed 2013–2013 |
| Clovis Oncology, Inc. CLVS | Officer | filed 2011–2013 |
| Workday, Inc. WDAY | Officer | filed 2012–2013 |
| Millennial Media Inc. MM | Officer | filed 2012–2012 |
| Medimmune INC /DE MEDI | Director · Vice Chairman, CEO, President | filed 2006–2007 |
All roles under one Commission-assigned identifier - the same person by the SEC's own record, not by name matching. From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.